Suven Life Sciences Limited Cash Flow Conversion Efficiency

Latest as of September 2025: -0.368x

Suven Life Sciences Limited cash flow conversion efficiency. Based on the latest financial reports, Suven Life Sciences Limited (SUVEN) has a cash flow conversion efficiency ratio of -0.368x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.03 Billion ≈ $-11.18 Million USD) by net assets (Rs2.81 Billion ≈ $30.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Suven Life Sciences Limited (2005–2025)

Cash flow conversion efficiency of Suven Life Sciences Limited from 2005 to 2025. This chart illustrates how Suven Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Suven Life Sciences Limited stock price today for real-time trading data and today's change.

Suven Life Sciences Limited Cash Flow Conversion Ratio Explained

Suven Life Sciences Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Suven Life Sciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suven Life Sciences Limited ranked by their cash flow conversion efficiency. Also see SUVEN market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Yijiahe Technology Co Ltd SHG:603666	-0.030x
B Communications Ltd TA:BCOM	0.170x
Zhongzhong Science & Technology (Tianjin) Co. Ltd. A SHG:603135	N/A
Kirloskar Ferrous Industries Limited NSE:KIRLFER	0.020x
Guangzhou Risong Intelligent Technology Holding Co Ltd SHG:688090	0.048x
Cresud SA BA:CRES	-0.021x
Ningbo Dechang Electrical Machinery Made Co Ltd SHG:605555	-0.019x
Xinyaqiang Silicon Chemistry Co Ltd SHG:603155	0.015x

Annual Cash Flow Conversion Efficiency for Suven Life Sciences Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Suven Life Sciences Limited from 2005 to 2025. Review Suven Life Sciences Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs1.10 Billion ≈ $11.89 Million	Rs-1.48 Billion ≈ $-16.06 Million	-1.350x	-215.69%
2024-03-31	Rs2.70 Billion ≈ $29.20 Million	Rs-1.15 Billion ≈ $-12.49 Million	-0.428x	-55.59%
2023-03-31	Rs3.75 Billion ≈ $40.59 Million	Rs-1.03 Billion ≈ $-11.16 Million	-0.275x	+79.28%
2022-03-31	Rs961.45 Million ≈ $10.40 Million	Rs-1.28 Billion ≈ $-13.79 Million	-1.327x	-49.20%
2021-03-31	Rs1.08 Billion ≈ $11.68 Million	Rs-960.24 Million ≈ $-10.38 Million	-0.889x	+34.25%
2020-03-31	Rs1.43 Billion ≈ $15.50 Million	Rs-1.94 Billion ≈ $-20.96 Million	-1.352x	-3261.03%
2019-03-31	Rs8.31 Billion ≈ $89.87 Million	Rs355.49 Million ≈ $3.84 Million	0.043x	-53.06%
2018-03-31	Rs7.67 Billion ≈ $82.99 Million	Rs699.36 Million ≈ $7.56 Million	0.091x	-44.15%
2017-03-31	Rs6.67 Billion ≈ $72.13 Million	Rs1.09 Billion ≈ $11.77 Million	0.163x	+39.04%
2016-03-31	Rs5.95 Billion ≈ $64.40 Million	Rs698.78 Million ≈ $7.56 Million	0.117x	-54.10%
2015-03-31	Rs5.59 Billion ≈ $60.49 Million	Rs1.43 Billion ≈ $15.46 Million	0.256x	-44.27%
2014-03-31	Rs2.64 Billion ≈ $28.60 Million	Rs1.21 Billion ≈ $13.12 Million	0.459x	+130.90%
2013-03-31	Rs1.54 Billion ≈ $16.70 Million	Rs306.86 Million ≈ $3.32 Million	0.199x	-24.39%
2012-03-31	Rs1.28 Billion ≈ $13.79 Million	Rs335.07 Million ≈ $3.62 Million	0.263x	+503.70%
2011-03-31	Rs1.27 Billion ≈ $13.71 Million	Rs55.16 Million ≈ $596.55K	0.044x	-60.24%
2010-03-31	Rs1.18 Billion ≈ $12.77 Million	Rs129.25 Million ≈ $1.40 Million	0.109x	-63.45%
2009-03-31	Rs1.14 Billion ≈ $12.38 Million	Rs342.73 Million ≈ $3.71 Million	0.299x	+709.03%
2008-03-31	Rs1.06 Billion ≈ $11.51 Million	Rs39.38 Million ≈ $425.92K	0.037x	-76.86%
2007-03-31	Rs1.02 Billion ≈ $10.98 Million	Rs162.41 Million ≈ $1.76 Million	0.160x	+161.76%
2006-03-31	Rs902.12 Million ≈ $9.76 Million	Rs55.13 Million ≈ $596.25K	0.061x	+135.07%
2005-03-31	Rs811.85 Million ≈ $8.78 Million	Rs21.11 Million ≈ $228.26K	0.026x	--

About Suven Life Sciences Limited

NSE:SUVEN India Drug Manufacturers - Specialty & Generic

Market Cap

$744.95 Million

Rs68.88 Billion INR

Market Cap Rank

#9875 Global

#498 in India

Share Price

Rs261.20

Change (1 day)

-3.88%

52-Week Range

Rs126.65 - Rs392.05

All Time High

Rs392.05